Literature DB >> 16192486

Severe sepsis and therapy with activated protein C.

Joseph E Parrillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16192486     DOI： 10.1056/NEJMe058160

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  An update on activated protein C (xigris) in the management of sepsis.

Authors:  Cesar Alaniz
Journal:  P T       Date:  2010-09

2.  Evaluation of drotrecogin alpha use in a Belgian university hospital.

Authors:  Isabel Spriet; Wouter Meersseman; Alexander Wilmer; Geert Meyfroidt; Minne Casteels; Ludo Willems
Journal:  Pharm World Sci       Date:  2006-11-17

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian design.

Authors:  Andre C Kalil; Junfeng Sun
Journal:  Intensive Care Med       Date:  2008-05-27       Impact factor: 17.440

5.  8 Inhibitors.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

6.  Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

Authors:  Franco Scaldaferri; Miquel Sans; Stefania Vetrano; Cristina Graziani; Raimondo De Cristofaro; Bruce Gerlitz; Alessandro Repici; Vincenzo Arena; Alberto Malesci; Julian Panes; Brian W Grinnell; Silvio Danese
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response.

Authors:  Po-Nien Tsao; Shu-Chen Wei; Miao-Tzu Huang; Ming-Cheng Lee; Hung-Chieh Chou; Chien-Yi Chen; Wu-Shiun Hsieh
Journal:  J Biomed Sci       Date:  2011-08-15       Impact factor: 8.410

8.  Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Beat Müller
Journal:  Endothelium       Date:  2007 Nov-Dec

9.  The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock.

Authors:  Chul-Su Yang; Sung-Ryong Ko; Byung-Goo Cho; Dong-Min Shin; Jae-Min Yuk; Shengjin Li; Jin-Man Kim; Ronald M Evans; Jun-Sub Jung; Dong-Keun Song; Eun-Kyeong Jo
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.